1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Ventricular Septal Defect Global Clinical Trials Review, H2, 2014

Ventricular Septal Defect Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Ventricular Septal Defect Global Clinical Trials Review, H2, 2014" provides data on the Ventricular Septal Defect clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Septal Defect. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Septal Defect. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Ventricular Septal Defect Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Ventricular Septal Defect 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in E7 Countries 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Ventricular Septal Defect 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Ventricular Septal Defect Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Asklepion Pharmaceuticals, LLC 28
Clinical Trial Overview of Asklepion Pharmaceuticals, LLC 28
Clinical Trial Overview of Top Institutes / Government 29
National Heart, Lung, and Blood Institute 29
Clinical Trial Overview of National Heart, Lung, and Blood Institute 29
Union Hospital 30
Clinical Trial Overview of Union Hospital 30
Helsinki University Central Hospital 31
Clinical Trial Overview of Helsinki University Central Hospital 31
Aarhus University 32
Clinical Trial Overview of Aarhus University 32
Seoul National University Hospital 33
Clinical Trial Overview of Seoul National University Hospital 33
Nationwide Children's Hospital 34
Clinical Trial Overview of Nationwide Children's Hospital 34
National Taiwan University Hospital 35
Clinical Trial Overview of National Taiwan University Hospital 35
All India Institute of Medical Sciences 36
Clinical Trial Overview of All India Institute of Medical Sciences 36
University of Pennsylvania 37
Clinical Trial Overview of University of Pennsylvania 37
National Center for Research Resources 38
Clinical Trial Overview of National Center for Research Resources 38
Five Key Clinical Profiles 39
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 57

List of Tables
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Region, 2014* 6
Ventricular Septal Defect Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ventricular Septal Defect Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Ventricular Septal Defect Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Ventricular Septal Defect Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 16
Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Ventricular Septal Defect Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Ventricular Septal Defect Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Ventricular Septal Defect Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepion Pharmaceuticals, LLC, 2014* 28
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 29
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Union Hospital, 2014* 30
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014* 31
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 32
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 33
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Nationwide Children's Hospital, 2014* 34
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 35
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 36
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 37
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 38

List of Figures
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Ventricular Septal Defect Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ventricular Septal Defect Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Ventricular Septal Defect Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 16
Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Ventricular Septal Defect Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Ventricular Septal Defect Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 56

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The Global market for Clinical Trial Management System is expected to reach $2 billion by the end of 2020 growing at a CAGR of around 12.5% from 2014 to 2021. Clinical Trial Management System is a system ...

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.